iRepertoire

Enrichment prior to amplification better enables studies of non-coding regions and epigenetic analyses, according to Ubiquity's founder.

Immune sequencing will be done in HudsonAlpha's newly established CLIA laboratory.

Researchers are demonstrating that sequencing the immune repertoire can offer valuable insight into blood cancers, treatment response, and the likelihood of relapse.

NEW YORK (GenomeWeb) – iRepertoire today announced a deal with Wiratech to distribute iRepertoire's reagent kits in parts of Europe.

NEW YORK (GenomeWeb News) – Sequenta has gained the exclusive rights to iRepertoire's IP related to methods of immune cell sequencing for minimal residual disease testing, the two companies said today.

Immune cell profiling company iRepertoire has launched a new line of reagents, amplification, and sequencing services on the Illumina MiSeq system.

The goal is to find personalized biomarkers in the immune system that will lead to better and earlier diagnostics.

T-cell receptor sequencing is "a long way from being used clinically," said Robert Holt, head of sequencing at the BC Cancer Agency's Genome Sciences Center and senior author of a recent paper on the subject.

Sequencing the immune repertoire could provide important insights into the nature of disease and infection, and new companies that offer such sequencing and analysis have recently sprung up.

Pages

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.